DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $779,039,000 | +71.6% | 3,461,009 | +69.3% | 0.60% | +54.4% |
| Q4 2020 | $454,086,000 | -32.6% | 2,044,080 | -34.7% | 0.39% | -45.4% |
| Q3 2020 | $674,110,000 | +64.9% | 3,130,643 | +35.4% | 0.71% | +46.1% |
| Q2 2020 | $408,823,000 | +48.4% | 2,312,073 | +9.0% | 0.48% | +0.8% |
| Q1 2020 | $275,497,000 | -11.0% | 2,121,539 | +5.2% | 0.48% | +32.2% |
| Q4 2019 | $309,437,000 | +4.0% | 2,016,128 | -2.1% | 0.36% | -18.2% |
| Q3 2019 | $297,503,000 | -47.7% | 2,059,962 | -25.7% | 0.44% | -4.5% |
| Q2 2019 | $568,576,000 | +58.3% | 2,770,943 | +1.9% | 0.46% | -7.9% |
| Q1 2019 | $359,071,000 | +30.0% | 2,719,833 | +1.5% | 0.50% | +98.8% |
| Q4 2018 | $276,255,000 | +12.7% | 2,678,959 | +18.7% | 0.25% | -20.9% |
| Q3 2018 | $245,178,000 | +36.0% | 2,256,375 | +23.5% | 0.32% | +23.5% |
| Q2 2018 | $180,334,000 | +15.0% | 1,827,454 | +14.1% | 0.26% | +3.6% |
| Q1 2018 | $156,775,000 | +162.9% | 1,601,225 | +149.2% | 0.25% | +172.8% |
| Q4 2017 | $59,642,000 | +1611.9% | 642,562 | +1762.6% | 0.09% | +607.7% |
| Q2 2016 | $3,484,000 | +1382.6% | 34,498 | +1291.6% | 0.01% | +1200.0% |
| Q1 2016 | $235,000 | -8.2% | 2,479 | -10.1% | 0.00% | 0.0% |
| Q4 2015 | $256,000 | -76.4% | 2,756 | -78.4% | 0.00% | -75.0% |
| Q3 2015 | $1,087,000 | +360.6% | 12,754 | +362.8% | 0.00% | +300.0% |
| Q2 2015 | $236,000 | -0.8% | 2,756 | -1.7% | 0.00% | 0.0% |
| Q1 2015 | $238,000 | -8.1% | 2,804 | -7.3% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | +0.4% | 3,024 | -10.8% | 0.00% | 0.0% |
| Q3 2014 | $258,000 | -95.2% | 3,391 | -95.0% | 0.00% | -95.2% |
| Q2 2014 | $5,367,000 | +2570.1% | 68,173 | +2445.7% | 0.02% | +2000.0% |
| Q1 2014 | $201,000 | -10.7% | 2,678 | -8.3% | 0.00% | 0.0% |
| Q4 2013 | $225,000 | -98.0% | 2,920 | -98.2% | 0.00% | -97.8% |
| Q3 2013 | $11,007,000 | +5243.2% | 158,792 | +4782.9% | 0.04% | +4400.0% |
| Q2 2013 | $206,000 | -66.1% | 3,252 | -70.1% | 0.00% | -66.7% |
| Q4 2012 | $607,000 | – | 10,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |